2028 Marketing Pharmacokinetics Small Molecule 
Drug Discovery World
SEPTEMBER 26, 2022
It’s also why pharmaceutical companies will look to acquire smaller biotechs and drug discovery companies, because a lot of the legwork into finding a suitable molecule for a disease has already been done. . This is a stark contrast to the often decade-long projects that pharmaceutical companies undertake to bring a drug to market.
The Pharma Data
SEPTEMBER 15, 2020
27 key programs highlighted, including assets that could potentially contribute revenue by 2025 and others in the 2026-2028 time frame. Phase 1 data and development plans for danuglipron (PF-06882961), which has the potential to be the first-ever small molecule oral GLP-1RA for treating obesity and type 2 diabetes.
Expert insights. Personalized for you.
130 
Let's personalize your content